HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Mitsunori Ushigome Selected Research
Mitsunori Ushigome Research Topics
Disease
12
Colorectal Neoplasms (Colorectal Cancer)
12/2023 - 03/2005
8
Neoplasms (Cancer)
12/2023 - 10/2003
6
Rectal Neoplasms (Rectal Cancer)
12/2023 - 01/2014
6
Neoplasm Metastasis (Metastasis)
12/2023 - 02/2011
2
Sigmoid Neoplasms
04/2021 - 11/2016
2
Colonic Neoplasms (Colon Cancer)
11/2016 - 10/2003
2
Carcinogenesis
03/2005 - 10/2003
1
Adenomatous Polyposis Coli (Familial Adenomatous Polyposis)
12/2023
1
Hypersensitivity (Allergy)
12/2023
1
Edema (Dropsy)
12/2021
1
Pericardial Effusion
12/2021
1
Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor)
12/2021
1
Rectal Prolapse
06/2021
1
Brain Neoplasms (Brain Tumor)
04/2021
1
Intracranial Aneurysm (Cerebral Aneurysm)
04/2021
1
Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage)
04/2021
1
Carcinoma (Carcinomatosis)
02/2020
1
Liver Neoplasms (Liver Cancer)
12/2019
1
Surgical Wound Infection
10/2018
1
Hemorrhage
11/2016
1
Infections
11/2016
1
Rupture
11/2016
1
Anemia
11/2016
1
Thoracic Aorta Dissection
11/2016
1
Fistula
11/2016
1
Fournier Gangrene
09/2016
1
Hernia (Hernias)
08/2014
1
Pathologic Constriction (Stenosis)
11/2013
1
Cecal Neoplasms
02/2011
1
Genomic Instability
03/2005
1
Aberrant Crypt Foci
10/2003
1
Hepatolenticular Degeneration (Wilson's Disease)
03/2003
Drug/Important Bio-Agent (IBA)
4
Bevacizumab (Avastin)
FDA Link
12/2023 - 11/2014
3
Carbohydrates
IBA
03/2023 - 04/2020
3
Carcinoembryonic Antigen
IBA
03/2023 - 04/2020
2
Antibodies
IBA
03/2023 - 04/2020
2
Antigens
IBA
03/2023 - 01/2022
2
Autoantibodies
IBA
01/2021 - 10/2018
2
Tumor Biomarkers (Tumor Markers)
IBA
04/2020 - 02/2011
1
Lipids
IBA
12/2023
1
Biosimilar Pharmaceuticals
IBA
12/2023
1
Panitumumab (Vectibix)
FDA Link
12/2023
1
Biomarkers (Surrogate Marker)
IBA
03/2023
1
Proteins (Proteins, Gene)
FDA Link
03/2023
1
C-Reactive Protein
IBA
01/2022
1
Imatinib Mesylate (Gleevec)
FDA Link
12/2021
1
Annexin A2 (Annexin II)
IBA
10/2018
1
Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
IBA
10/2018
1
Neoplasm Antigens (Tumor Antigens)
IBA
10/2018
1
XELOX
IBA
11/2016
1
Hemoglobins (Hemoglobin)
IBA
11/2016
1
Colloids (Colloid)
IBA
11/2014
1
Radioactive Tracers
IBA
11/2014
1
ErbB Receptors (EGF Receptor)
IBA
11/2014
1
Heterogeneous Nuclear Ribonucleoprotein A1
IBA
03/2005
1
2- amino- 1- methyl- 6- phenylimidazo(4,5- b)pyridine
IBA
10/2003
1
Carcinogens
IBA
10/2003
1
benzocycloheptapyridine
IBA
10/2003
1
Soybean Proteins (Soy Protein)
IBA
03/2003
Therapy/Procedure
7
Therapeutics
12/2023 - 02/2011
5
Drug Therapy (Chemotherapy)
12/2023 - 11/2013
3
Stents
10/2018 - 11/2013
2
Neoadjuvant Therapy
12/2023 - 11/2013
2
Palliative Care (Palliative Therapy)
01/2023 - 11/2016
2
Radiotherapy
12/2019 - 01/2014
1
Restorative Proctocolectomy
12/2023
1
Chemoradiotherapy
01/2023
1
Drug Tapering
12/2021
1
Operative Surgical Procedures
06/2021
1
Hepatectomy
04/2021
1
Radiofrequency Ablation
04/2021
1
Proctectomy
02/2020
1
Surgical Amputation (Amputations)
02/2020
1
Length of Stay
10/2018
1
Ostomy
10/2018
1
Decompression
10/2018
1
Combined Modality Therapy
09/2016
1
Lymph Node Excision (Lymph Node Dissection)
11/2014
1
Colostomy
08/2014